Kodiak Sciences Inc.

NASDAQ:KOD

Biotechnology

Healthcare
$97.81 -0.08%

-$0.03 today

Market cap
$6.40B
Beta
2.21
P/E (TTM)
-9.6
EPS (TTM)
-$3.73
52W Low $3.43High $47.84

Volume 0.74M

Average 1.10M

KOD Total Debt

Short-term and long-term borrowings combined.

Kodiak Sciences Inc.NASDAQ: KOD

Total Debt · Q3 FY2026 · quarter ended Sep 2026

Total debt rises 135.6% from a year ago

Total debt stood at $146.56M at the end of Q3 FY2026, up 135.6% from a year earlier and up 53.1% from the prior quarter. Over 3 fiscal years it compounded at -5.4% a year.

Context

  • Total debt amounted to 70.0% of total assets at the end of Q3 FY2026, up 41.5 pp from a year earlier.
  • Total debt increased in 1 of the last 3 fiscal years.

What to watch

Whether total debt keeps rising in the next quarterly balance sheet after a +135.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$146.56M+53.1% QoQ
Last fiscal yearDec 2025
$159.18M+126.3% YoY
Year agoSep 2025
$62.2M+135.6% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+135.6%——
1 year+126.3%——
3-year CAGR-5.4%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
159.18M USD
Year-over-year change
+126.3%
4-year CAGR
-3.0%

Total Debt vs competitors

How KOD compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +135.6% is the highest of 9, against a peer median of -5.4%.
  • Total debt amounts to 70.0% of total assets for KOD, versus a peer median of 7.0%.
KOD Competitors
Total Debt for KOD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BLCOBausch + Lomb CorporationJun 2026$5.12B USD+3.1%+28.1%36.9%
REGNRegeneron Pharmaceuticals, Inc.Jun 2026$1.99B USD-26.6%+0.1%4.8%
KODKodiak Sciences Inc.Sep 2026$146.56M USD+135.6%-5.4%70.0%
OCULOcular Therapeutix, Inc.Mar 2026$79.46M USD+4.2%+7.5%10.8%
OCGNOcugen, Inc.Mar 2026$33.3M USD+4.6%+73.2%58.5%
OTLKOutlook Therapeutics, Inc.Mar 2026$27.19M USD-18.4%+40.2%124.2%
FDMT4D Molecular Therapeutics, Inc.Mar 2026$20.54M USD-13.9%+9.9%4.0%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$20.23M USD-16.0%-23.5%7.0%
OCSOculis Holding AGMar 2026CHF 2.24M CHF+103.2%-73.4%0.9%
BLTEBelite Bio, IncJun 2026$0 USD—-20.9%0.0%
Peer median (excluding KOD) —-5.4%+7.5%7.0%

Competitors are the stored peer set for KOD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents731.51M190.43M285.51M168.07M209.86M
Short-term Investments0288.5M000
Net Receivables00000
Inventory00000
Other Current Assets3.3M7.07M3.8M3.86M4.95M
Total Current Assets734.81M486.01M289.31M171.94M214.82M
Property, Plant & Equipment (Net)108.07M115.75M175.02M148.73M121.86M
Goodwill00000
Intangible Assets00000
Long-term Investments6.32M6.32M6.32M6.18M6.18M
Tax Assets00000
Other Non-current Assets55.01M58.55M8.72M8.73M8.67M
Total Non-current Assets169.41M180.62M190.06M163.64M136.72M
Total Assets904.22M666.63M479.37M335.58M351.53M
Account Payables12.43M9.13M13.61M3.92M12.86M
Short-term Debt3.93M9.93M9.77M012.06M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities42.13M27.41M12.27M012.84M
Total Current Liabilities64.68M52.5M41.73M25.57M45.53M
Long-term Debt99.94M100M100M0100M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities211K162K0100M1.5M
Total Non-current Liabilities176.22M177.97M171.86M159.72M148.62M
Total Liabilities240.9M230.46M213.59M185.29M194.15M
Common Stock5K5K5K5K6K
Retained Earnings(558.22M)(892.04M)(1.15B)(1.33B)(1.56B)
Accumulated OCI0(1.31M)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity663.32M436.17M265.78M150.29M157.38M
Total Debt179.94M187.73M181.63M70.35M159.18M
Net Debt(551.57M)(2.7M)(103.88M)(97.73M)(50.68M)

Kodiak Sciences Inc.

NASDAQ:KOD

Intrinsic Alpha fair value

Locked

Current Price

$97.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.